Orient Pharma Co., Ltd. Yunlin Plant recalls

Orient Pharma Co., Ltd. Yunlin Plant has 2 recalls on record with the FDA and USDA, the earliest in 2025 and the latest reported on 9 Jul 2025. 2 are still ongoing. The most frequent reason is potency & assay.

Total recalls2since 2025

Last 12 months0reported

Class I00% of total

Ongoing2latest 9 Jul 2025

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 2Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 0 0%Class III 2 100%

Why orient pharma co., ltd. yunlin plant is recalled

Potency & Assay2100%

By year

20252100%

Ongoing orient pharma co., ltd. yunlin plant recalls

2 active

Reported	Class	Recall	Company	Reason	Where
9 Jul 2025Drug	CLASS III	Pitavastatin Tablets, 2 mg recalled by Orient Pharma Co., Ltd.Pitavastatin	Orient Pharma Co., Ltd. Yunlin Plant	Potency & Assay	NJ
9 Jul 2025Drug	CLASS III	Pitavastatin Tablets, 1 mg recalled by Orient Pharma Co., Ltd.Pitavastatin	Orient Pharma Co., Ltd. Yunlin Plant	Potency & Assay	NJ

All orient pharma co., ltd. yunlin plant recalls, newest first

2 total

Reported	Class	Recall	Company	Reason	Where
9 Jul 2025Drug	CLASS III	Pitavastatin Tablets, 2 mg recalled by Orient Pharma Co., Ltd.Pitavastatin	Orient Pharma Co., Ltd. Yunlin Plant	Potency & Assay	NJ
9 Jul 2025Drug	CLASS III	Pitavastatin Tablets, 1 mg recalled by Orient Pharma Co., Ltd.Pitavastatin	Orient Pharma Co., Ltd. Yunlin Plant	Potency & Assay	NJ

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.